1. Home
  2. PULM vs MOGU Comparison

PULM vs MOGU Comparison

Compare PULM & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • MOGU
  • Stock Information
  • Founded
  • PULM 2003
  • MOGU 2011
  • Country
  • PULM United States
  • MOGU China
  • Employees
  • PULM N/A
  • MOGU N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • PULM Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • PULM 18.3M
  • MOGU 19.8M
  • IPO Year
  • PULM N/A
  • MOGU 2018
  • Fundamental
  • Price
  • PULM $4.84
  • MOGU $2.53
  • Analyst Decision
  • PULM
  • MOGU
  • Analyst Count
  • PULM 0
  • MOGU 0
  • Target Price
  • PULM N/A
  • MOGU N/A
  • AVG Volume (30 Days)
  • PULM 4.3K
  • MOGU 9.6K
  • Earning Date
  • PULM 10-16-2025
  • MOGU 11-21-2025
  • Dividend Yield
  • PULM N/A
  • MOGU N/A
  • EPS Growth
  • PULM N/A
  • MOGU N/A
  • EPS
  • PULM N/A
  • MOGU N/A
  • Revenue
  • PULM $3,000.00
  • MOGU $19,462,964.00
  • Revenue This Year
  • PULM N/A
  • MOGU N/A
  • Revenue Next Year
  • PULM $134.88
  • MOGU N/A
  • P/E Ratio
  • PULM N/A
  • MOGU N/A
  • Revenue Growth
  • PULM N/A
  • MOGU N/A
  • 52 Week Low
  • PULM $4.26
  • MOGU $1.83
  • 52 Week High
  • PULM $10.40
  • MOGU $8.10
  • Technical
  • Relative Strength Index (RSI)
  • PULM 47.70
  • MOGU 39.67
  • Support Level
  • PULM $4.26
  • MOGU $2.54
  • Resistance Level
  • PULM $4.85
  • MOGU $2.65
  • Average True Range (ATR)
  • PULM 0.24
  • MOGU 0.14
  • MACD
  • PULM -0.02
  • MOGU -0.00
  • Stochastic Oscillator
  • PULM 61.11
  • MOGU 9.09

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

Share on Social Networks: